While metformin has been a diabetes staple for decades, GLP-1 medications like semaglutide represent a newer approach that directly signals your body's appetite and blood sugar centers
Clinical evidence shows that patients often report feeling fuller faster and experiencing less food cravings within 37 days of their first dose
If it still fails, its usually one of three things: you hit the savings cap, your plan blocks manufacturer cards, or eligibility data doesnt match
Gastrointestinal issuessuch as nausea, vomiting, or diarrheaare the most common side effects, especially when starting treatment
Statistical analysis Continuous variables were summarized as medians [interquartile range (IQR)]
Ozempic (semaglutide) is clinically approved for managing type 2 diabetesnot as a general weight loss drug, explains Dr